ACQUISITION & DIVESTITURE: LICENSING

Regulatory Services
Mergers and Acquisition

Need
• Investor group sought to purchase small, but profitable pharmaceutical company
• Advice required on regulatory status of products

Approach
• Conducted legal due diligence and identified several DESI drugs with questionable regulatory status; clients identified certain products for acquisition and wished to proceed with transaction
• Negotiated and drafted a stock purchase agreement secured by Promissory Note with repayment of purchase price over three years from net profits

Benefits
• Clients able to significantly increase sales allowing for payment of principal and providing operating capital to expand operations

Learn More.

COPYRIGHT 2006 - BioVerum Partners